Naimish Patel, Chief Medical Officer at CRISPR Therapeutics AG (CRSP), bought 1,508 shares at $32.96 ($50K) on 2025-04-03, disclosed to the SEC on 2026-01-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2025-05-30 | $283K | — | Filing → |